» Articles » PMID: 37774944

Gut-muscle-brain Axis: Molecular Mechanisms in Neurodegenerative Disorders and Potential Therapeutic Efficacy of Probiotic Supplementation Coupled with Exercise

Overview
Specialties Neurology
Pharmacology
Date 2023 Sep 29
PMID 37774944
Authors
Affiliations
Soon will be listed here.
Abstract

Increased longevity is often associated with age-related conditions. The most common neurodegenerative disorders in the older population are Alzheimer's disease (AD) and Parkinson's disease (PD), associated with progressive neuronal loss leading to functional and cognitive impairments. Although symptomatic treatments are available, there is currently no cure for these conditions. Gut dysbiosis has been involved in the pathogenesis of AD and PD, thus interventions targeting the "gut-brain axis" could potentially prevent or delay these pathologies. Recent evidence suggests that the skeletal muscle and the gut microbiota can affect each other via the "gut-muscle axis". Importantly, cognitive functions in AD and PD patients significantly benefit from physical activity. In this review, we aim to provide a comprehensive picture of the crosstalk between the brain, the skeletal muscle and the gut microbiota, introducing the concept of "gut-muscle-brain axis". Moreover, we discuss human and animal studies exploring the modulatory role of exercise and probiotics on cognition in AD and PD. Collectively, the findings presented here support the potential benefits of physical activity and probiotic supplementation in AD and PD. Further studies will be needed to develop targeted and multimodal strategies, including lifestyle changes, to prevent or delay the course of these pathologies.

Citing Articles

Mediating role of gut microbiota on Baduanjin for cognitive function in community-dwelling older adults with mild cognitive impairment: a study protocol for a cluster randomised controlled trial.

Sun L, Geng Q, Zheng G BMJ Open. 2024; 14(11):e087684.

PMID: 39578030 PMC: 11590836. DOI: 10.1136/bmjopen-2024-087684.


as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature.

Beltran-Velasco A, Reiriz M, Uceda S, Echeverry-Alzate V Int J Mol Sci. 2024; 25(5).

PMID: 38474254 PMC: 10931784. DOI: 10.3390/ijms25053010.